Deutsch English Français

Contact

EP2548594

European procedure

Unitary Patent

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2548594

EP2548594 - Intrathecal baclofen pharmaceutical dosage forms and related delivery system [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 17.05.2024 Database last updated on 02.11.2024
Former	The patent has been granted Status updated on 09.06.2023
Former	Grant of patent is intended Status updated on 08.01.2023
Former	Examination is in progress Status updated on 28.11.2017
Most recent event Tooltip	12.07.2024	Lapse of the patent in a contracting state New state(s): IE	published on 14.08.2024 [2024/33]
Applicant(s)	For all designated states Piramal Critical Care Inc. 3950 Schelden Circle Bethlehem, PA 18017 / US
	[2023/26]
Former [2017/23]	For all designated states Piramal Critical Care Limited 450, Regus Offices Bath Road Longford Heathrow UB7 0EB / GB
Former [2017/23]	For all designated states Piramal Critical Care Limited 450, Regus Offices Bath Road Longford Heathrow UB7 0EB / GB
Former [2013/24]	For all designated states Mallinckrodt LLC 675 McDonnell Boulevard St. Louis, MO 63042 / US
Former [2013/04]	For all designated states CNS Therapeutics, Inc. 539 Bielenberg Drive Suite 200 Woodbury, MN 55125 / US
Inventor(s)	01 / Foster, John CNS Therapeutics Inc. 539 Bielenberg Drive Suite 200 Woodbury, MN 55125 / US
	02 / Prentice, Thomas R. CNS Therapeutics Inc. 539 Bielenberg Drive Suite 200 Woodbury, MN 55125 / US
	[2013/04]
Representative(s)	HGF HGF Limited 1 City Walk Leeds LS11 9DX / GB
	[2023/28]
Former [2014/26]	Jones, Nicholas Andrew, et al Withers & Rogers LLP 4 More London Riverside London SE1 2AU / GB
Former [2013/16]	Albrecht, Thomas Kraus & Weisert Patent- und Rechtsanwälte Thomas-Wimmer-Ring 15 80539 München / DE
Former [2013/04]	Müller-Boré & Partner Patentanwälte Grafinger Straße 2 81671 München / DE
Application number, filing date	11006015.9	22.07.2011
	[2013/04]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	EP2548594
	Date:	23.01.2013
	Language:	EN
	[2013/04]
	Type:	B1 Patent specification
	No.:	EP2548594
	Date:	12.07.2023
	Language:	EN
	[2023/28]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	03.07.2012
Classification	IPC:	A61K9/00, A61M5/315, A61K9/08, A61K31/197, A61P21/02	[2023/01]
	CPC:	A61M5/31511 (EP); A61K31/197 (EP); A61K9/0019 (EP); A61K9/08 (EP); A61P21/02 (EP); A61M2205/6081 (EP)
	Former IPC [2013/04]	A61M5/00
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/28]
Former [2013/04]	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Title	German:	Intrathekale pharmazeutische Baclofen-Dosisformen und zugehöriges Abgabesystem	[2013/04]
	English:	Intrathecal baclofen pharmaceutical dosage forms and related delivery system	[2013/04]
	French:	Formes de dosage pharmaceutiques de baclofène intrathécal et système de distribution associé	[2013/04]
Examination procedure	18.07.2013	Amendment by applicant (claims and/or description)
	18.07.2013	Examination requested [2013/35]
	07.08.2015	Despatch of a communication from the examining division (Time limit: M04)
	17.12.2015	Reply to a communication from the examining division
	17.11.2017	Despatch of a communication from the examining division (Time limit: M04)
	23.03.2018	Reply to a communication from the examining division
	04.10.2022	Cancellation of oral proceeding that was planned for 09.12.2022
	07.10.2022	Despatch of a communication from the examining division (Time limit: M04)
	28.10.2022	Reply to a communication from the examining division
	09.12.2022	Date of oral proceedings (cancelled)
	09.01.2023	Communication of intention to grant the patent
	05.05.2023	Fee for grant paid
	05.05.2023	Fee for publishing/printing paid
	05.05.2023	Receipt of the translation of the claim(s)
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 07.08.2015
Opposition(s)	15.04.2024	No opposition filed within time limit [2024/25]
Fees paid	Renewal fee
	29.07.2013	Renewal fee patent year 03
	28.07.2014	Renewal fee patent year 04
	27.07.2015	Renewal fee patent year 05
	27.07.2016	Renewal fee patent year 06
	30.06.2017	Renewal fee patent year 07
	04.07.2018	Renewal fee patent year 08
	01.07.2019	Renewal fee patent year 09
	15.07.2020	Renewal fee patent year 10
	13.07.2021	Renewal fee patent year 11
	30.06.2022	Renewal fee patent year 12
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	CZ	12.07.2023
	HR	12.07.2023
	MC	12.07.2023
	PL	12.07.2023
	RO	12.07.2023
	RS	12.07.2023
	SK	12.07.2023
	SM	12.07.2023
	IE	22.07.2023
	CH	31.07.2023
	NO	12.10.2023
	GR	13.10.2023
	IS	12.11.2023
	[2024/33]
Former [2024/23]	CZ	12.07.2023
	HR	12.07.2023
	MC	12.07.2023
	PL	12.07.2023
	RO	12.07.2023
	RS	12.07.2023
	SK	12.07.2023
	SM	12.07.2023
	CH	31.07.2023
	NO	12.10.2023
	GR	13.10.2023
	IS	12.11.2023
Former [2024/20]	HR	12.07.2023
	PL	12.07.2023
	RS	12.07.2023
	SM	12.07.2023
	NO	12.10.2023
	GR	13.10.2023
	IS	12.11.2023
Former [2024/11]	HR	12.07.2023
	PL	12.07.2023
	RS	12.07.2023
	NO	12.10.2023
	GR	13.10.2023
	IS	12.11.2023
Former [2024/09]	NO	12.10.2023
	GR	13.10.2023
	IS	12.11.2023
Former [2024/08]	NO	12.10.2023
	GR	13.10.2023
Documents cited:	Search	[A]US6629954 (HERUTH KENNETH T [US]) [A] 1-10 * abstract * * paragraph [0014] ** figure 1 *;
		[X]US2005004219 (HILDEBRAND KEITH R [US], et al) [X] 1-10 * abstract * * paragraph [0041] * * claims 18,30 * * figures 4,5 *;
		[A]US2010056989 (MCKAY WILLIAM F [US]) [A] 1-10 * abstract * * figure - *;
		[X]US2010106097 (ELMOUELHI AHMED [US]) [X] 1-10 * claim - * * figure 5 *
	Examination	WO2007035621
		WO2011163647
	by applicant	US7824697

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p